Perigon Wealth Management LLC Acquires Shares of 4,607 Danaher Corporation $DHR

Perigon Wealth Management LLC bought a new position in Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 4,607 shares of the conglomerate’s stock, valued at approximately $3,317,000.

A number of other large investors have also recently made changes to their positions in DHR. Sivia Capital Partners LLC increased its stake in Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after buying an additional 119 shares during the period. First Trust Advisors LP raised its stake in shares of Danaher by 34.5% during the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after acquiring an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC boosted its holdings in shares of Danaher by 40.2% in the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after purchasing an additional 886 shares during the period. Ieq Capital LLC boosted its holdings in shares of Danaher by 64.2% in the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after purchasing an additional 29,592 shares during the period. Finally, HUB Investment Partners LLC lifted its holdings in shares of Danaher by 30.7% in the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after buying an additional 325 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Down 0.0%

Shares of Danaher stock opened at $202.44 on Tuesday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a market cap of $142.31 billion, a P/E ratio of 35.96, a PEG ratio of 2.52 and a beta of 0.78. The firm’s 50 day moving average price is $193.52 and its 200-day moving average price is $192.67. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same period last year, the firm earned $0.77 earnings per share. Danaher’s revenue was up 5.5% compared to the same quarter last year. On average, sell-side analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analysts Set New Price Targets

DHR has been the subject of a number of research reports. Morgan Stanley lowered their price objective on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Jefferies Financial Group reaffirmed a “buy” rating and issued a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. TD Cowen dropped their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Stifel Nicolaus reduced their price objective on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Finally, Piper Sandler started coverage on Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.